A personalized mRNA therapy met two melanoma trial goals, the FDA cleared the first treatment for GSDIa, and Novo tests lower ...
Stay ahead of the biggest ideas in financial markets and global economics with the Money Talks newsletter. From Wall Street to Shanghai, our journalists offer expert analysis and original ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results